Maccura Biotechnology Co Ltd - Asset Resilience Ratio

Latest as of June 2026: 0.58%

Maccura Biotechnology Co Ltd (300463) has an Asset Resilience Ratio of 0.58% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 300463 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥45.11 Million

≈ $6.60 Million USD Cash + Short-term Investments

Total Assets

CN¥7.82 Billion

≈ $1.14 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2025)

This chart shows how Maccura Biotechnology Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Maccura Biotechnology Co Ltd total assets.

Liquid Assets Composition Over Time

This chart breaks down Maccura Biotechnology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Maccura Biotechnology Co Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥45.11 Million	0.58%
Total Liquid Assets	CN¥45.11 Million	0.58%

Asset Resilience Insights

Limited Liquidity: Maccura Biotechnology Co Ltd maintains only 0.58% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Maccura Biotechnology Co Ltd Industry Peers by Asset Resilience Ratio

Compare Maccura Biotechnology Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
GeneDx Holdings Corp. NASDAQ:WGS	Diagnostics & Research	15.00%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Healius Ltd AU:HLS	Diagnostics & Research	0.06%
Microba Life Sciences Ltd AU:MAP	Diagnostics & Research	11.53%
Genetic Signatures Ltd AU:GSS	Diagnostics & Research	60.91%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%

Annual Asset Resilience Ratio for Maccura Biotechnology Co Ltd (2015–2025)

The table below shows the annual Asset Resilience Ratio data for Maccura Biotechnology Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.63%	CN¥50.18 Million ≈ $7.34 Million	CN¥7.99 Billion ≈ $1.17 Billion	-0.13pp
2024-12-31	0.75%	CN¥60.06 Million ≈ $8.79 Million	CN¥7.98 Billion ≈ $1.17 Billion	-3.08pp
2023-12-31	3.83%	CN¥311.14 Million ≈ $45.53 Million	CN¥8.12 Billion ≈ $1.19 Billion	-4.30pp
2022-12-31	8.13%	CN¥663.72 Million ≈ $97.12 Million	CN¥8.16 Billion ≈ $1.19 Billion	+5.23pp
2017-12-31	2.90%	CN¥104.00 Million ≈ $15.22 Million	CN¥3.58 Billion ≈ $524.33 Million	-8.92pp
2016-12-31	11.82%	CN¥319.00 Million ≈ $46.68 Million	CN¥2.70 Billion ≈ $394.85 Million	-15.16pp
2015-12-31	26.98%	CN¥640.00 Million ≈ $93.65 Million	CN¥2.37 Billion ≈ $347.12 Million	--

pp = percentage points

About Maccura Biotechnology Co Ltd

SHE:300463 China Diagnostics & Research

Market Cap

$817.57 Million

CN¥5.59 Billion CNY

Market Cap Rank

#9901 Global

#2586 in China

Share Price

CN¥9.24

Change (1 day)

+0.87%

52-Week Range

CN¥8.11 - CN¥14.20

All Time High

CN¥59.01